New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
09:23 EDTGRFS, ING, EXAS, HALO, AMGN, PRAN, CRIS, SINA, MNKD, LULUOn The Fly: Pre-market Movers
HIGHER: Lululemon (LULU), up 3% following upgrade at Wedbush... SINA (SINA), up 3.5% after upgraded at Pacific Crest... Grifols (GRFS), up 2.5% after announcing 7-year agreement with Japanese Red Cross... Exact Sciences (EXAS), up 3.6% after Barron's says shares could rise 50%... Curis (CRIS), up 11% after announcing removal of FDA partial clinical hold on CUDC-427... Halozyme (HALO), up 9% after announcing that trial of Hylenex recombinant met primary endpoint... ING (ING), up 4.5% after paying EUR1.23B to Dutch State... Amgen (AMGN), up 2% after AMG 145 reduced LDL cholesterol in statin intolerant patients... LOWER: Prana (PRAN), down 66% after Alzheimer's study doesn't hit targets... MannKind (MNKD), down 5.6% after downgraded at Piper Jaffray.
News For LULU;MNKD;PRAN;EXAS;SINA;AMGN;ING;CRIS;HALO;GRFS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
March 24, 2015
16:50 EDTINGING Groep downgraded to Neutral from Buy at Goldman
Subscribe for More Information
09:10 EDTAMGNDako announces collaboration agreement with Amgen
Dako, an Agilent Technologies (A) company, announced a new Master Collaboration Agreement with Amgen (AMGN). The expanded collaboration will allow both companies to benefit from knowledge-sharing within the field of drug-diagnostic research and development in general, and in relation to companion diagnostic products in particular. The financial details of the agreement were not disclosed.
05:46 EDTMNKDStocks with implied volatility movement; AMZN MNKD
Subscribe for More Information
March 23, 2015
13:50 EDTLULUAnalysts take opposite sides on lululemon before Q4 report
Subscribe for More Information
12:10 EDTAMGNTeva migraine drug data positive for Amgen, says Piper Jaffray
Piper Jaffray said the "positive" trial data Teva (TEVA) reported for its anti-CGRP antibody in migraines is another important validation for the class of drugs that is also being worked on by Amgen (AMGN), Eli Lilly (LLY) and Alder Biopharmaceuticals (ALDR). The firm said it thinks Amgen is one of the leaders in CGRP antibody space and reiterated its Overweight rating and $187 price target on Amgen shares.
09:03 EDTAMGNLeerink analysts hold a meeting with a conference call hookup
Subscribe for More Information
08:58 EDTLULUlululemon should be bought ahead of earnings on Thursday, says Cowen
Cowen said the risk/reward is good for lululemon ahead of its earnings report on Thursday and recommends buying shares ahead of the event. The firm cited improved product, controlled markdowns, and potential online traffic gains. Cowen reiterated its Outperform rating and $70 price target on lululemon shares.
07:42 EDTLULUlululemon subject to sharp pullback if momentum pauses, says Canaccord
Subscribe for More Information
07:36 EDTLULUlululemon volatility elevated into Q4 and outlook
Subscribe for More Information
March 20, 2015
16:00 EDTMNKDOptions Update; March 20, 2015
Subscribe for More Information
09:06 EDTAMGNAmgen submits application for marketing approval for RepathaTM in Japan
Subscribe for More Information
07:41 EDTAMGNAmerican Academy of Dermatology to hold annual meeting
Subscribe for More Information
March 19, 2015
17:26 EDTINGING Groep files automatic mixed securities shelf
Subscribe for More Information
15:55 EDTAMGNAmgen injunction bid for Neupogen biosimilar denied, Reuters reports
Subscribe for More Information
15:13 EDTAMGNAmgen denied preliminary injunction for biologics against Novartis, Reuters says
07:16 EDTLULUlululemon volatility elevated into Q4 and outlook
lululemon March weekly call option implied volatility is at 74, April is at 46, June is at 38, September is at 36; compared to its 26-week average of 36 according to Track Data, suggesting large near term price movement into the expected release of Q4 on March 26.
March 18, 2015
10:21 EDTINGHigh option volume stocks:
Subscribe for More Information
09:32 EDTMNKDMannKind faces cash shortfall if $100M debt not settled, TheStreet says
Subscribe for More Information
March 17, 2015
16:11 EDTAMGNAmgen to present 10 abstracts from dermatology portfolio
Subscribe for More Information
08:45 EDTHALOHalozyme management to meet with JPMorgan
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use